Cadrenal Therapeutics, Inc. vs Cel-Sci Corporation — Valuation Comparison 2026
Access all valuation models for CVKD vs CVM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →CVKD scores higher with a 4.7/10 quality rating vs CVM's 3.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Cadrenal Therapeutics, Inc. (CVKD) and Cel-Sci Corporation (CVM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
CVKD currently trades at $5.00 with a QOC of 4.7/10, while CVM trades at $1.48 with a QOC of 3.3/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).